# A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants

> **NCT06143904** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 10 (actual)

## Conditions studied

- Gaucher's Disease Type I

## Interventions

- **DRUG:** Genz-112638
- **DRUG:** Genz-112638
- **DRUG:** [14C]-Genz-112638

## Key facts

- **NCT ID:** NCT06143904
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-03
- **Primary completion:** 2009-07-05
- **Final completion:** 2009-07-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143904, "A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06143904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*